To mark this special occasion, some of the country’s most respected health experts from various specialties come together to ...

A new UK study has found that women working permanent night shifts face a significantly higher risk of moderate to severe ...

And if at these screenings, people could also be assisted to help quit smoking, that would not only decrease the incidence of lung cancer but also bring down smoking rates and reduce other smoking ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...

Chronic pain, sexual dysfunction and incontinence can all stem from problems with your pelvic floor — and many men don’t even ...

“This research shows that people with COPD seem to gather a lot more carbon in their lung cells. These cells also look and ...

In a statement on the approval, GSK said that a lower threshold means that nearly 70% of COPD patients in the US who are inadequately controlled on inhaled triple therapy could be eligible for Nucala.

New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.